CLVS

Clovis Oncology, Inc.

Delisted

CLVS was delisted on the 20th of December, 2022.

153 hedge funds and large institutions have $200M invested in Clovis Oncology, Inc. in 2019 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 66 increasing their positions, 33 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
153
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$28.4M
Puts
$23.8M
Net Calls
Net Calls Change

Top Buyers

1 +$8.04M
2 +$6.61M
3 +$6.47M
4
Two Sigma Investments
Two Sigma Investments
New York
+$3.41M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$3.19M

Top Sellers

1 -$28.4M
2 -$17.1M
3 -$14.2M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5.84M
5
Rafferty Asset Management
Rafferty Asset Management
New York
-$5.46M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$19.2M
2
$18.6M
3
$17.7M
4
$14.2M
5
$13.5M
6
$12.1M
7
$8.26M
8
$6.93M
9
$5.86M
10
$4.45M
11
$4.19M
12
$4.17M
13
$3.9M
14
$3.64M
15
$2.92M
16
$2.82M
17
$2.79M
18
$2.48M
19
$2.31M
20
$2.02M
21
$1.97M
22
$1.72M
23
$1.7M
24
$1.63M
25
$1.55M